We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

QFLS:QSEQatar Fuel-Woqod QSC Analysis

Data as of 2026-05-24 - not real-time

QAR 14.15

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

QFLS is trading at roughly QAR 14.15, which sits well above its DCF‑derived fair value of about QAR 5.8, signaling a material pricing premium. The stock’s trailing PE of 14.4 is comfortably below the industry average of 21.6, suggesting relative earnings attractiveness. However, revenue has contracted by over 20% year‑over‑year and margins remain thin, limiting organic growth prospects. The company generates solid operating cash flow and maintains a modest debt‑to‑equity of roughly 13%, providing a stable balance sheet. A high dividend yield of 6.36% is attractive, though the payout ratio hovers near 92%, raising questions about long‑term sustainability. Overall, the fundamentals paint a classic “value” profile with income appeal but constrained growth.
On the technical side, the 20‑day SMA sits below the 50‑day and 200‑day SMAs, confirming a bearish price momentum. RSI at 40 indicates the stock is not yet oversold, while the MACD histogram has turned slightly positive, hinting at a tentative short‑term bounce. Volume trends are weakening, and price is flirting with the identified support around QAR 14.01, making downside risk palpable. Volatility over the past month is modest at about 9%, and the beta is effectively neutral, limiting market‑wide swings. The combination of the high dividend yield, limited upside, and bearish technical signals leads to an cautious stance. Investors should weigh the income benefit against the pricing premium and consider a hold in the near term, with a potential shift to a longer‑term buy if the dividend can be maintained.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bearish SMA alignment (20‑day below 50‑day and 200‑day)
  • Decreasing volume trend
  • Price near identified support level

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Valuation premium relative to DCF fair value
  • Strong dividend yield with high payout ratio
  • Modest operating cash flow and low debt

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Attractive dividend yield for income‑focused investors
  • Stable balance sheet and low leverage
  • Potential for earnings stabilization as market conditions normalize

Key Metrics & Analysis

Financial Health

Revenue Growth-21.30%
Profit Margin3.95%
P/E Ratio14.4
ROE11.64%
ROA2.74%
Debt/Equity12.63
P/B Ratio1.6
Op. Cash FlowQAR870.9M
Free Cash FlowQAR360.2M
Industry P/E21.6

Technical Analysis

TrendBearish
RSI40.4
SupportQAR 14.01
ResistanceQAR 14.54
MA 20QAR 14.23
MA 50QAR 14.43
MA 200QAR 14.93
MACDBullish
VolumeDecreasing
Fear & Greed Index91.61

Valuation

Fair ValueQAR 5.81
Target PriceQAR 15.36
Upside/Downside8.55%
GradeOvervalued
TypeValue
Dividend Yield6.36%

Risk Assessment

Beta-0.04
Volatility9.02%
Sector RiskMedium
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.